CryoPort (CryoPort) Interest Expense : $-5.3 Mil (TTM As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is CryoPort Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. CryoPort's interest expense for the three months ended in Mar. 2024 was $ -1.3 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-5.3 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. CryoPort's Operating Income for the three months ended in Mar. 2024 was $ -21.3 Mil. CryoPort's Interest Expense for the three months ended in Mar. 2024 was $ -1.3 Mil. CryoPort did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CryoPort Interest Expense Historical Data

The historical data trend for CryoPort's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CryoPort Interest Expense Chart

CryoPort Annual Data

Trend

Mar14

Mar15

Mar16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-1.37

-2.56

-4.69

-6.14

-5.50

CryoPort Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-1.51	-1.33	-1.36	-1.31	-1.34

CryoPort Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.3 Mil.

CryoPort (NAS:CYRX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CryoPort's Interest Expense for the three months ended in Mar. 2024 was $-1.3 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-21.3 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $409.2 Mil.

CryoPort's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

CryoPort did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

CryoPort (CryoPort) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » CryoPort Inc (NAS:CYRX) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

CKX:Germany

Address

112 Westwood Place, Suite 350, Brentwood, TN, USA, 37027

Website

https://www.cryoport.com

CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.

Executives

Robert J Hariri	director	341 MENDHAM ROAD, BERNARDSVILLE NJ 07924
Jerrell Shelton	director, officer: President, CEO	C/O NETRATINGS INC, 120 WEST 45TH STREET 35TH FLOOR, NEW YORK NY 10036
Richard J Berman	director	305 COLLEGE ROAD EAST, PRINCETON NJ 08540
Robert Stefanovich	officer: Chief Financial Officer
Mark W Sawicki	officer: Chief Scientific Officer	3303 LAKEPOINTE DRIVE, BELMONT NC 28012
Blackstone Holdings Ii L.p.	10 percent owner	C/O BLACKSTONE INC., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Tactical Opportunities Fund - Fd L.p.	10 percent owner	C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Daniel M Hancock	director	7729 S. BELMONT, INDIANAPOLIS IN 46217
Edward J Zecchini	director	20382 BARENTS SEA CIRCLE, LAKE FOREST CA 92630
Linda Baddour	director	PRA INTERNATIONAL, 12120 SUNSET HILLS ROAD, SUITE 600, RESTON VA 20190
Ramkumar Mandalam	director	4344 PICKEREL DRIVE, UNION CITY CA 94587
Ram M. Jagannath	director	C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Stephen A Schwarzman	10 percent owner	C/O BLACKSTONE INC., 345 PARK AVE, NEW YORK NY 10154
Blackstone Tactical Opportunities Associates Iii - Nq L.p.	10 percent owner	C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Freeze Parent L.p.	10 percent owner	C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154